Salinomycin and its derivatives as potent RET transcriptional inhibitors for the treatment of medullary thyroid carcinoma (MTC)

Journal article

Open access

Peer reviewed

The FASEB journal, Vol.34(S1), pp.1-1

04/2020

Files and links (1)

url

https://doi.org/10.1096/fasebj.2020.34.s1.05420View

Published (Version of record) Open

1 Record Views

Title: Salinomycin and its derivatives as potent RET transcriptional inhibitors for the treatment of medullary thyroid carcinoma (MTC)
Creators - without role: Tariq M. Alqahtani - University of Arizona
Daekyu M. Sun - University of Arizona
Publication Details: The FASEB journal, Vol.34(S1), pp.1-1
Identifiers: 9918162308331
Academic Unit: Majmaah University
Language: English
Resource Type: Journal article